Jiwon Jung
ORCID: 0000-0003-4333-3270Also affiliated with Sino Biopharmaceutical (China), Leibniz Institute of Environmental Medicine, Korea University, Erasmus University Rotterdam, Delft University of Technology
Pilot corpus only
This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.
Indexed papers
Why this DataRank?
An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.
Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.
Read the full methodology →Papers
Driven by 3 papers. Top paper: “Clinical characteristics of COVID-19 rebound after nirmatrelvir-ritonavir or molnupiravir therapy: A prospective cohort study”.
Seongman Bae, Jiwon Jung, Min Jae Kim, Yong Pil Chong, Sang-Oh Lee +5 more
Saleh Mahmood, Jiwon Jung, Todd C. Rideout, Mulchand S. Patel
Eujin Park, Kyung Hee Han, Ji Yeon Song, Seong Heon Kim, Naye Choi +15 more